Ga. Mansoor et Wb. White, CIRCADIAN BLOOD-PRESSURE VARIATION IN HYPERTENSIVE PATIENTS WITH PRIMARY HYPERALDOSTERONISM, Hypertension, 31(3), 1998, pp. 843-847
A less-than-normal decline in nocturnal blood pressure (BP) has been a
ssociated with excessive hypertensive complications. This is concernin
g because secondary hypertension is often associated with this so-call
ed nondipper BP profile. A nondipping pattern is more frequently found
in the presence of pheochromocytoma, Cushing's syndrome, and sleep ap
nea syndrome, but the prevalence is unclear in patients with primary h
yperaldosteronism. We therefore studied ambulatory BP profiles in 16 h
ypertensive patients with primary hyperaldosteronism and an equal numb
er of essential hypertensive subjects. The awake-sleep BP difference o
f the hyperaldosteronism patients was similar to that of essential hyp
ertensives (15/14+/-3/2 versus 14/9+/-3/2 mm Hg, P=NS). The prevalence
of dippers and nondippers (according to two distinct criteria) in the
two groups was similar. Repeat ambulatory BP monitoring in 12 subject
s with primary hyperaldosteronism after specific intervention (3 after
surgical removal of an adrenal adenoma and 9 after commencement and t
itration of spironolactone therapy) showed highly significant: reducti
ons in office BP (22/10+/-6/4 mm Hg, P<.05) and awake and sleep BP. Ho
wever, the extent of nocturnal BP decline was unchanged between the tw
o studies (17/16+/-3/3 versus 16/12+/-2/2 mm Hg, P=NS). There was no c
ell-elation between the awake-sleep difference and serum or urinary al
dosterone levels or the aldosterone-to-renin ratio. In this study, we
did not detect any differences in the awake-sleep differences between
a group of hypertensives with primary hyperaldosteronism and a control
group of essential hypertensives.